看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Trend | Peers | Company |
|---|---|---|
| Is return on equity increasing? | No | No |
| Is net profit margin increasing? | No | Yes |
| Is asset turnover increasing? | Yes | Yes |
| Is equity multiplier increasing? | Yes | No |
| Competitors Used |
|---|
| ADMA Biologics, Inc. |
| Grifols, S.A. |
| Entera Bio Ltd. |
| Pluri Inc. |
| XTL Biopharmaceuticals Ltd. |
| Return on Equity Benchmarks | ||||||||
| Comparable Companies | ||||||||
| ADMA | GRF | ENTX | PLUR | XTLB | KMDA | |||
| Return On Equity | ||||||||
| Latest Twelve Months | 82% | 3% | -103% | NM | -26% | 6% | ||
| Fiscal Year - 1 | -20% | 1% | NA | -131% | NA | 4% | ||
| Fiscal Year - 2 | -45% | 3% | -76% | -95% | NA | -1% | ||
| Fiscal Year - 3 | -62% | 4% | -81% | NA | NA | -1% | ||
| Fiscal Year - 4 | -132% | 12% | -115% | -75% | NA | 11% | ||
| Fiscal Year - 5 | -210% | 14% | -98% | -140% | NA | 18% | ||
| Average | -65% | 6% | -95% | -110% | -26% | 6% | ||
| Median | -54% | 3% | -98% | -113% | -26% | 5% | ||
| Benchmarks | Ticker | |||||||
| ADMA Biologics, Inc. | NasdaqGM:ADMA | |||||||
| Grifols, S.A. | BME:GRF | |||||||
| Entera Bio Ltd. | NasdaqCM:ENTX | |||||||
| Pluri Inc. | TASE:PLUR | |||||||
| XTL Biopharmaceuticals Ltd. | TASE:XTLB | |||||||
| Financial Performance | ||||||||
| Comparable Companies | ||||||||
| (in millions) | ADMA | GRF | ENTX | PLUR | XTLB | KMDA | ||
| Latest Fiscal Year | Dec-24 | Dec-24 | Dec-24 | Jun-24 | Dec-23 | Dec-24 | ||
| LTM Period | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Sep-24 | Dec-24 | ||
| Revenues | ||||||||
| Latest Twelve Months | 426 | 7,212 | 0 | 1 | 0 | 161 | ||
| Fiscal Year | 426 | 7,212 | 0 | 0 | NA | 161 | ||
| Fiscal Year - 1 | 258 | 6,592 | NA | 0 | NA | 143 | ||
| Fiscal Year - 2 | 154 | 6,064 | 0 | 0 | NA | 129 | ||
| Fiscal Year - 3 | 81 | 4,933 | 1 | NA | NA | 104 | ||
| Fiscal Year - 4 | 42 | 5,340 | 0 | 0 | NA | 133 | ||
| Fiscal Year - 5 | 29 | 5,099 | 0 | 0 | NA | 127 | ||
| Net Income | ||||||||
| Latest Twelve Months | 198 | 157 | (10) | (20) | (1) | 14 | ||
| Fiscal Year | 198 | 157 | (10) | (21) | (2) | 14 | ||
| Fiscal Year - 1 | (28) | 42 | (9) | (28) | (1) | 8 | ||
| Fiscal Year - 2 | (66) | 185 | (13) | (41) | 0 | (2) | ||
| Fiscal Year - 3 | (72) | 189 | (12) | (50) | (3) | (2) | ||
| Fiscal Year - 4 | (76) | 619 | (11) | (29) | (1) | 17 | ||
| Fiscal Year - 5 | (48) | 625 | (11) | (35) | 4 | 22 | ||
| Total Assets | ||||||||
| Latest Fiscal Quarter Prior | 329 | 20,992 | 12 | 42 | 3 | 355 | ||
| Latest Fiscal Quarter | 489 | 21,405 | 9 | 31 | 9 | 372 | ||
| Fiscal Year | 489 | 21,405 | 9 | 40 | 2 | 372 | ||
| Fiscal Year - 1 | 329 | 20,992 | 12 | 51 | 4 | 355 | ||
| Fiscal Year - 2 | 348 | 21,230 | 13 | 68 | 7 | 322 | ||
| Fiscal Year - 3 | 276 | 19,234 | 26 | 94 | 7 | 319 | ||
| Fiscal Year - 4 | 208 | 15,275 | 10 | 66 | 7 | 211 | ||
| Fiscal Year - 5 | 127 | 15,543 | 17 | 31 | 9 | 174 | ||
| Fiscal Year - 6 | 89 | 12,477 | 13 | 39 | 7 | 138 | ||
| Common Equity | ||||||||
| Latest Fiscal Quarter Prior | 135 | 5,368 | 10 | 4 | 3 | 244 | ||
| Latest Fiscal Quarter | 349 | 5,884 | 8 | (8) | 6 | 259 | ||
| Fiscal Year | 349 | 5,884 | 8 | 0 | 2 | 259 | ||
| Fiscal Year - 1 | 135 | 5,368 | 10 | 13 | 4 | 244 | ||
| Fiscal Year - 2 | 152 | 5,649 | 12 | 30 | 5 | 176 | ||
| Fiscal Year - 3 | 141 | 5,524 | 23 | 57 | 4 | 177 | ||
| Fiscal Year - 4 | 88 | 5,108 | 8 | 56 | 7 | 179 | ||
| Fiscal Year - 5 | 26 | 4,822 | 12 | 22 | 7 | 135 | ||
| Fiscal Year - 6 | 20 | 4,226 | 10 | 29 | 4 | 112 | ||